Can ruxolitinib replace hydroxyurea as a frontline therapy for PV?

Описание к видео Can ruxolitinib replace hydroxyurea as a frontline therapy for PV?

During IACH 2023, the MPN Hub spoke with Claire Harrison, Guy's and St Thomas' NHS Foundation Trust, London, UK. We asked, Can ruxolitinib replace hydroxyurea as a frontline therapy for polycythemia vera?

Комментарии

Информация по комментариям в разработке